Abbott Laboratories (ABT) Shares Outstanding: 1.75
Is Abbott Laboratories’s shares outstanding high or low?
Abbott Laboratories's shares outstanding of 1.75 is in line with its 5-year average of 1.75, around the middle of its 5-year range (1.73–1.77).
The shares outstanding for Abbott Laboratories (ABT) is 1.75. It is above its 12-month average by 0.44% (1.74).
ABT Shares Outstanding Chart
ABT Average Shares Outstanding Chart
ABT Current vs Average Shares Outstanding Chart
ABT Shares Outstanding Metrics
SHARES OUTSTANDING
1.75
SHARES OUTSTANDING AVG TTM
1.74
SHARES OUTSTANDING AVG 3Y
1.74
SHARES OUTSTANDING AVG 5Y
1.75
SHARES OUTSTANDING AVG 10Y
1.70
SHARES OUTSTANDING AVG 15Y
1.65
SHARES OUTSTANDING AVG 20Y
1.63
CURRENT VS TTM AVG
+0.44%
CURRENT VS 3Y AVG
+0.32%
CURRENT VS 5Y AVG
-0.30%
CURRENT VS 10Y AVG
+2.62%
CURRENT VS 15Y AVG
+5.57%
CURRENT VS 20Y AVG
+7.30%
Share Structure
Shares Outstanding
1.75B
Float Shares
N/A
Stock Price
$91.25
Market Cap
$158.9B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 1.75B | +0.88% |
| 2024 | 1.73B | -0.14% |
| 2023 | 1.73B | -1.08% |
| 2022 | 1.75B | -1.24% |
| 2021 | 1.77B | +0.11% |
| 2020 | 1.77B | +0.28% |
| 2019 | 1.77B | +0.71% |
| 2018 | 1.76B | +0.69% |
| 2017 | 1.74B | +18.38% |
| 2016 | 1.47B | +0.01% |
| 2015 | 1.47B | -2.35% |
| 2014 | 1.51B | -2.59% |
| 2013 | 1.55B | -1.81% |
| 2012 | 1.58B | +0.40% |
| 2011 | 1.57B | +1.51% |
| 2010 | 1.55B | +0.03% |
| 2009 | 1.55B | +0.19% |
| 2008 | 1.54B | +0.03% |
| 2007 | 1.54B | +0.87% |
| 2006 | 1.53B | -1.46% |
| 2005 | 1.55B | -0.52% |
| 2004 | 1.56B | -0.14% |
| 2003 | 1.56B | +0.12% |
| 2002 | 1.56B | +0.68% |
| 2001 | 1.55B | +0.15% |
| 2000 | 1.55B | +0.73% |
| 1999 | 1.54B | -0.03% |
| 1998 | 1.54B | -0.92% |
| 1997 | 1.55B | -0.24% |
| 1996 | 1.56B | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Abbott Laboratories Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Abbott Laboratories Shares Outstanding FAQ
- What is the shares outstanding for Abbott Laboratories (ABT)?
- The shares outstanding for ABT stock is 1.75.
- Is Abbott Laboratories's shares outstanding high or low?
- Abbott Laboratories's shares outstanding of 1.75 is in line with its 5-year average of 1.75, around the middle of its 5-year range (1.73–1.77).
- What is the TTM average shares outstanding for Abbott Laboratories (ABT)?
- The TTM average shares outstanding for ABT stock is 1.74.
- What is the 3Y average shares outstanding for Abbott Laboratories (ABT)?
- The 3Y average shares outstanding for ABT stock is 1.74.
- What is the 5Y average shares outstanding for Abbott Laboratories (ABT)?
- The 5Y average shares outstanding for ABT stock is 1.75.
- What is the 10Y average shares outstanding for Abbott Laboratories (ABT)?
- The 10Y average shares outstanding for ABT stock is 1.70.
- What is the 15Y average shares outstanding for Abbott Laboratories (ABT)?
- The 15Y average shares outstanding for ABT stock is 1.65.
- What is the 20Y average shares outstanding for Abbott Laboratories (ABT)?
- The 20Y average shares outstanding for ABT stock is 1.63.
Abbott Laboratories Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 1.75 |
| 2024-12-31 | 1.73 |
| 2023-12-31 | 1.73 |
| 2022-12-31 | 1.75 |
| 2021-12-31 | 1.77 |
| 2020-12-31 | 1.77 |
| 2019-12-31 | 1.77 |
| 2018-12-31 | 1.76 |
| 2017-12-31 | 1.74 |
| 2016-12-31 | 1.47 |
| 2015-12-31 | 1.47 |
| 2014-12-31 | 1.51 |
| 2013-12-31 | 1.55 |
| 2012-12-31 | 1.58 |
| 2011-12-31 | 1.57 |
| 2010-12-31 | 1.55 |
| 2009-12-31 | 1.55 |
| 2008-12-31 | 1.54 |
| 2007-12-31 | 1.54 |
| 2006-12-31 | 1.53 |
| 2005-12-31 | 1.55 |
| 2004-12-31 | 1.56 |
| 2003-12-31 | 1.56 |
| 2002-12-31 | 1.56 |
| 2001-12-31 | 1.55 |
| 2000-12-31 | 1.55 |
| 1999-12-31 | 1.54 |
| 1998-12-31 | 1.54 |
| 1997-12-31 | 1.55 |
| 1996-12-31 | 1.56 |
Related Metrics
About Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Robert Ford